Genome-Wide Association Study Implicates Chromosome 9q21.31 as a Susceptibility Locus for Asthma in Mexican Children by Hancock, Dana B. et al.
 
Genome-Wide Association Study Implicates Chromosome 9q21.31
as a Susceptibility Locus for Asthma in Mexican Children
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Hancock, Dana B., Isabelle Romieu, Min Shi, Juan-Jose Sienra-
Monge, Hao Wu, Grace Y. Chiu, Huiling Li, et al. 2009. Genome-
Wide Association Study Implicates Chromosome 9q21.31 as a
Susceptibility Locus for Asthma in Mexican Children. PLoS
Genetics 5(8): e1000623.
Published Version doi:10.1371/journal.pgen.1000623
Accessed February 19, 2015 8:27:37 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:4887116
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAGenome-Wide Association Study Implicates
Chromosome 9q21.31 as a Susceptibility Locus for
Asthma in Mexican Children
Dana B. Hancock
1, Isabelle Romieu
2, Min Shi
3, Juan-Jose Sienra-Monge
4, Hao Wu
5, Grace Y. Chiu
6,
Huiling Li
5, Blanca Estela del Rio-Navarro
4, Saffron A. G. Willis-Owens
7, Scott T. Weiss
8, Benjamin A.
Raby
8, Hong Gao
9, Celeste Eng
10, Rocio Chapela
11, Esteban G. Burchard
10, Hua Tang
9, Patrick F.
Sullivan
12, Stephanie J. London
1,5*
1Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle
Park, North Carolina, United States of America, 2Instituto Nacional de salud Publica, Cuernavaca, Mexico, 3Biostatistics Branch, National Institute of Environmental Health
Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, United States of America, 4Hospital Infantil de
Mexico Federico Gomez, Mexico City, Mexico, 5Laboratory of Respiratory Biology, National Institute of Environmental Health Sciences, National Institutes of Health,
Department of Health and Human Services, Research Triangle Park, North Carolina, United States of America, 6Westat, Research Triangle Park, North Carolina, United
States of America, 7Molecular Genetics, National Heart and Lung Institute, Imperial College, London, United Kingdom, 8Channing Laboratory, Brigham and Women’s
Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, 9Department of Genetics, Stanford University, Stanford, California, United States
of America, 10Department of Biopharmaceutical Sciences, University of California San Francisco, San Francisco, California, United States of America, 11Instituto Nacional
de Enfermedades Respiratorias, Mexico City, Mexico, 12Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of
America
Abstract
Many candidate genes have been studied for asthma, but replication has varied. Novel candidate genes have been
identified for various complex diseases using genome-wide association studies (GWASs). We conducted a GWAS in 492
Mexican children with asthma, predominantly atopic by skin prick test, and their parents using the Illumina HumanHap
550 K BeadChip to identify novel genetic variation for childhood asthma. The 520,767 autosomal single nucleotide
polymorphisms (SNPs) passing quality control were tested for association with childhood asthma using log-linear regression
with a log-additive risk model. Eleven of the most significantly associated GWAS SNPs were tested for replication in an
independent study of 177 Mexican case–parent trios with childhood-onset asthma and atopy using log-linear analysis. The
chromosome 9q21.31 SNP rs2378383 (p=7.10610
26 in the GWAS), located upstream of transducin-like enhancer of split 4
(TLE4), gave a p-value of 0.03 and the same direction and magnitude of association in the replication study (combined
p=6.79610
27). Ancestry analysis on chromosome 9q supported an inverse association between the rs2378383 minor allele
(G) and childhood asthma. This work identifies chromosome 9q21.31 as a novel susceptibility locus for childhood asthma in
Mexicans. Further, analysis of genome-wide expression data in 51 human tissues from the Novartis Research Foundation
showed that median GWAS significance levels for SNPs in genes expressed in the lung differed most significantly from
genes not expressed in the lung when compared to 50 other tissues, supporting the biological plausibility of our overall
GWAS findings and the multigenic etiology of childhood asthma.
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Introduction
Asthma (OMIM 600807) is a leading chronic childhood disease
with prevalence rates reaching a historically high level (8.9%) in
the United States and continuing to increase in many countries
worldwide [1,2]. Asthma is characterized by airway inflammation
and bronchoconstriction leading to airflow obstruction, but the
mechanisms leading to asthma development remain unknown.
Genetic risk factors likely play a central role in asthma
development. Twin studies support a strong genetic component
to asthma (especially childhood asthma) with heritability estimates
suggesting that 48–79% of asthma risk is attributable to genetic
risk factors [3]. In an effort to localize disease susceptibility genes,
genome-wide linkage studies have identified at least 20 linkage
regions potentially harboring disease genes [4], and over 100
positional and biological candidate genes have been tested for
PLoS Genetics | www.plosgenetics.org 1 August 2009 | Volume 5 | Issue 8 | e1000623association with asthma [3]. However, no genes have been
definitely shown to influence this complex disease.
Genome-wide association studies (GWASs) have emerged as a
powerful approach for identifying novel candidate genes for
common, complex diseases. In the first asthma GWAS, using
307,328 single nucleotide polymorphisms (SNPs), Moffatt et al.
found highly statistically significant associations of SNPs in
adjacent genes ORM1-like (S. cerevisiae) (ORMDL3; OMIM
610075) and gasdermin B (GSDMB or GSDML; OMIM 611221)
with risk of childhood asthma in German and British populations
[5]. Meta-analysis of the Moffatt et al. study and five subsequent
replication studies, including our own study, supports the
association of ORMDL3 and GSDML SNPs with risk for childhood
asthma across various populations [6]. More recently, using
518,230 SNPs, Himes et al. implicated SNPs in phosphodiesterase 4D,
cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) (PDE4D;
OMIM 600129) with risk of asthma in whites from the United
States and replicated this finding in two other white populations
[7]. Using only 97,112 SNPs, Choudhry et al. implicated
chromosome 5q23 SNPs for association with asthma in Puerto
Ricans [8], but no other Puerto Rican cohorts are available for
replication.
Few genetic studies of asthma have included Hispanic popula-
tions, and replication of positive genetic findings is scarce across
Hispanic groups. Hispanics have differing proportions of Native
American, European, and African ancestries. This admixture
introduces special considerations (such as controlling for population
stratification in association studies), but admixture in Hispanic
populations also provides a unique opportunity to use ancestry
analysis to evaluate our genetic association findings [9,10].
Mexico City is one of the most polluted cities in the world, and its
inhabitants experience chronic ozone exposure, which has been
linked to asthma development in children and adults and asthma
exacerbations [11–13]. We conducted a GWAS to identify novel
candidate susceptibility genes associated with childhood asthma in
case-parent trios from Mexico City and tested the most significantly
associated SNPs in an independent study of trios of Mexican
ethnicity. GWAS findings were then examined in the context of
ancestry analysis and genome-wide expression data to provide
supportive evidence for associations with childhood asthma.
Results
In the GWAS, there were more male (58.7%) than female
(41.3%) children with asthma, and the mean age at enrollment was
9.062.4 years (Table 1). The replication study had a similar
distribution of males (59.7%) to females (40.3%), but there was an
older mean age at enrollment distribution of 13.465.4 years. All
GWAS and replication study subjects with asthma were clinically
diagnosed before age 18.
Author Summary
Asthma is a leading chronic childhood disease with a
presumed strong genetic component, but no genes have
been definitely shown to influence asthma development.
Few genetic studies of asthma have included Hispanic
populations. Here, we conducted a genome-wide associ-
ation study of asthma in 492 Mexican children with
asthma, predominantly atopic by skin prick test, and their
parents to identify novel genetic variation for childhood
asthma. We implicated several polymorphisms in or near
TLE4 on chromosome 9q21.31 (a novel candidate region
for childhood asthma) and replicated one polymorphism in
an independent study of childhood-onset asthmatics with
atopy and their parents of Mexican ethnicity. Hispanics
have differing proportions of Native American, European,
and African ancestries, and we found less Native American
ancestry than expected at chromosome 9q21.31. This
suggests that chromosome 9q21.31 may underlie ethnic
differences in childhood asthma and that future replication
would be most effective in populations with Native
American ancestry. Analysis of publicly available ge-
nome-wide expression data revealed that association
signals in genes expressed in the lung differed most
significantly from genes not expressed in the lung when
compared to 50 other tissues, supporting the biological
plausibility of the overall GWAS findings and the multi-
genic etiology of asthma.
Table 1. Demographic and clinical characteristics of the 492 children with asthma.
Characteristic Category N (%) or Mean (SD
a)
Age at enrollment in years, mean (SD
a) 9.0 (2.4)
Sex, N (%) Male 289 (58.7)
Female 203 (41.3)
Asthma severity, N (%)
b Mild 339 (72.3)
Moderate/Severe 130 (27.7)
Skin test positivity (out of 24 aeroallergens), N (%)
b 0 allergens 37 (8.3)
1–4 allergen(s) 179 (40.2)
$5 allergens 229 (51.5)
Percent predicted FEV1, mean (SD
a) 90.5 (16.8)
Parental smoking, N (%) Mother smoked during pregnancy 23 (4.8)
Current smoking parent 253 (52.1)
Residential ambient ozone exposure (annual average of
the daily maximum 8 hour averages)
b
#67 ppb 199 (48.2)
.67 ppb 214 (51.8)
aSD, standard deviation.
bNumbers do not sum to 492 because of missing data. Percentages are based on non-missing data for each characteristic.
doi:10.1371/journal.pgen.1000623.t001
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children with asthma evaluated in the GWAS are presented in
Table 1. More children had mild asthma (72.3%) than moderate
to severe asthma (27.7%). Among the 445 children with skin prick
test data, nearly all (91.7%) were atopic based on having a positive
skin test to at least one aeroallergen. Few mothers reported
smoking during pregnancy (4.8%), but at least one parent
currently smoked in about half of the families. The median
annual average of the daily maximum 8 hour averages, a measure
of residential ambient ozone exposure, was 67 parts-per-billion
(ppb). The residence of 48.2% of the children had a low ambient
ozone exposure (#67 ppb), and the residence of 51.8% of the
children had a high exposure (.67 ppb).
Genome-wide association scan
The 520,767 autosomal SNPs passing quality control were
tested for association with childhood asthma using additive
modeling with the log-linear method in 492 children with asthma
and their biological parents from Mexico City. Not surprisingly
given the study size, no SNP met genome-wide significance using a
conservative Bonferroni adjustment. Nonetheless, the comparison
of observed and expected p-values in the quantile-quantile plot
(Figure 1) shows several top SNPs with some deviation from
expectation. These deviations may occur by chance or may
represent a true excess of small p-values.
Figure 2 shows the observed p-values plotted against chromo-
somal location. An intergenic SNP on chromosome 16 had
the most significant association with childhood asthma [rs1867612
(p=1.55610
26)], followed by an intronic SNP in potassium voltage-
gated channel, Shab-related subfamily, member 2 (KCNB2; OMIM
607738) on chromosome 8 [rs2247572 (p=1.94610
26)] and
two intergenic SNPs on chromosome 20 [rs6063725
(p=3.52610
26)] and rs720810 (p=5.13610
26)] with only
moderate linkage disequilibrium (LD) (r
2=0.59). The next most
significant SNP (rs2378383) highlights a cluster of SNPs on
chromosome 9q21.31 ranking among the top GWAS SNPs. This
cluster of SNPs spans transducin-like enhancer of split 4 (E(sp1) homolog,
Drosophila)( TLE4; OMIM 605132) and its upstream region. LD
analysis of SNPs with p#0.001 in this cluster shows two large LD
blocks in this region with one block encompassing TLE4 and the
other block encompassing the upstream region (Figure S1).
Replication of top findings
Eleven of the 18 most significantly associated SNPs met our
criteria to be selected for replication in 177 case-parent trios of
Mexican ethnicity from the Genetics of Asthma in Latino
Americans (GALA) study [14]. The GWAS p-values for the 11
SNPs selected for replication testing ranged from 3.30610
25 to
1.55610
26 (Figure 2). There were no significant deviations in
Hardy-Weinberg equilibrium (HWE) for the replication SNPs in
either the GWAS or replication study (p.0.12), and minor allele
frequencies (MAFs) were similar between the two studies (Table 2).
The replication study had at least 70% power to detect an
association with four SNPs (rs2378377, rs4674039, rs1830206, and
rs3814593) and at least 80% power to detect an association with the
remaining seven SNPs (rs1867612, rs2247572, rs6063725,
rs720810, rs2378383, rs6951506, and rs3734083) for similar MAFs
and relative risk (RR) estimates observed in the GWAS.
Association results in the GWAS and replication studies are
compared in Table 2. No SNPs were significant with conservative
Bonferroni correction for multiple testing, but two SNPs were
associated with childhood asthma in the replication study with a p-
value close to 0.05. The chromosome 9q21.31 SNP rs2378383,
which is located 147 kb upstream of TLE4 in an intergenic region
between coiled-coil-helix-coiled-coil-helix domain containing 9 (CHCHD9)
and TLE4, was associated with childhood asthma in the
replication study with p=0.03. Meta-analysis of rs2378383 in
the two studies gave a combined p-value of 6.79610
27, and the
RR estimate for carrying one copy of the rs2378383 minor allele
(G) compared to carrying no copies in the GWAS [RR, 0.61; 95%
confidence interval (CI), 0.49–0.76] was quite similar to the RR
estimate in the replication study (RR, 0.63; 95% CI, 0.41–0.96).
The SNP rs2378377, a neighboring intergenic SNP in moderate
LD with rs2378383 (r
2=0.73), had a marginal association with
childhood asthma in the replication study with p=0.06 (combined
p=2.68610
26). RR estimates for the rs2378377 minor allele (G)
were also similar between the GWAS (RR, 0.64; 95% CI, 0.53–0.79)
and the replication study (RR, 0.71; 95%CI, 0.50–1.02). None of
the other nine SNPs were associated in the replication study (Table 2).
Association results from additive modeling for SNPs in the
region spanning TLE4 and its upstream region (chromosome 9
nucleotide positions from 81,114,500 to 81,531,500, NCBI build
36.3) were obtained from the previous GWASs of asthma [5,7,8].
Our top two SNPs from this region were genotyped only in the
GWAS in whites from the United States [7], where they were not
associated with asthma (p=0.59 for rs2378383 and p=0.65 for
rs2378377). Eighty-nine other SNPs were available in this region,
and the smallest p-value was observed for rs1328406 (p=0.056).
There were 54 SNPs available in this region from the GWAS in
German and British populations [5], with the smallest p-values
observed for rs2807312 (p=0.0041), rs7849719 (p=0.018),
rs7862187 (p=0.033), rs10491790 (p=0.043), and rs946808
(p=0.049). From the 26 SNPs available from the GWAS in
Puerto Ricans [8], the smallest p-value was 0.19. In our GWAS in
Mexicans, there were several SNPs in TLE4 and its upstream
region with small p-values, and the SNPs listed above are located
in close proximity to many of our associated SNPs. Similar to our
GWAS and replication study, only cases with childhood-onset
asthma were included in both GWASs in white populations [5,7],
and the cases from Himes et al. were predominantly atopic
(91.2%) as defined by at least one positive skin prick test [7]. In
Figure 1. Quantile-quantile plot. Observed log-linear p-values
(black dots) and the corresponding expected log-linear p-values (red
line) are plotted on the logarithmic scale for the 520,767 autosomal
GWAS SNPs tested for association with childhood asthma.
doi:10.1371/journal.pgen.1000623.g001
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onset and adulthood-onset asthma cases, and 83% of the cases
were considered atopic as defined by total IgE.100 IU/mL [8].
Associations in the presence and absence of
environmental exposures
Associations of rs2378383 and rs2378377 were examined in
data from the GWAS population stratified by residential ambient
ozone exposure (199 trios with #67 ppb and 214 trios
with.67 ppb annual average of the maximum 8 hour averages)
and by current parental smoking (253 trios with and 233 trios
without current parental smoking). The minor alleles of both SNPs
were inversely associated with asthma at p,0.05 in all strata
(results not shown), thus giving no evidence for effect modification
in the presence of these environmental exposures.
Associations in asthmatic children with atopy
Among the 445 cases with skin test data available, 408 can be
classified as atopic by virtue of having at least one positive skin test.
We repeated the GWA scan in this subset of 408 trios.
Chromosome 9q21.31 SNPs predominated among the top ranked
SNPs, with rs2378383 (p=7.18610
27) and rs2378377
(p=1.08610
26) being the two top ranking SNPs. In addition to
smaller p-values, the magnitudes of association with asthma were
slightly stronger for rs2378383 (RR, 0.54; 95% CI, 0.42–0.69) and
rs2378377 (RR, 0.54; 95% CI, 0.42–0.72) in the subset of trios
where the asthmatic child is also known to be atopic.
The chromosome 9q21.31 SNPs rs2378383 and rs2378377
were tested for association with the number of positive skin tests as
a quantitative measure of the degree of atopy in the trios with skin
test data. Both SNPs were associated with degree of atopy
(p=0.0018 for rs2378383 and p=0.0010 for rs2378377). Their
RR estimates indicate an inverse association in which carrying one
copy of the minor allele is associated with a decreasing number of
positive skin tests (RR, 0.92; 95% CI, 0.87–0.97 for rs2378383 and
RR, 0.92; 95% CI, 0.88–0.97 for rs2378377), consistent with the
direction of association for asthma.
Ancestry analysis
The Mexican subjects in the GWAS had mean ancestral
proportions of 69.5615.6% for Native American, 27.3614.3% for
European, and 3.263.0% for African ancestries. Given the
Figure 2. Physical location of GWAS p-values. Observed log-linear p-values on the logarithmic scale are sorted by physical location on the 22
autosomes for the 520,767 SNPs tested for association with childhood asthma. The 11 of the top 18 SNPs selected for replication are located at or
above the solid line (p#3.3610
25).
doi:10.1371/journal.pgen.1000623.g002
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American transmission in the GWAS along the chromosomal arm
(9q) containing the replicated SNP (rs2378383) by ancestry
analysis. As shown in Figure 3, there is a significant under-
transmission of Native American ancestry at rs2378383 (z-
score=22.21 and two-sided p=0.028) and surrounding SNPs.
The deficiency in Native American ancestry at this locus
suggests that a protective allele occurred at a higher frequency in
the Native American ancestral population than in the European
and African ancestral populations. An examination of this SNP in
the HapMap and Human Genome Diversity Panel (HGDP) data
reveals that the frequency of the G allele is generally low in
European, African, and East Asian populations (0.125 in HapMap
European, 0.033 in HapMap African, 0.122 in HapMap Chinese,
and 0.273 in HapMap Japanese), while its frequency is much
higher in Native American populations (0.57 in HGDP Pima and
0.36 in HGDP Mayan). This pattern suggests that the G allele may
be tagging a protective allele in the Native American ancestral
Figure 3. Chromosome 9q21.31 ancestry analysis. Segregation of Native American ancestry was tested along chromosome 9q21.31, the
chromosomal region containing the replicated SNP (rs2378383). A 2,000 SNP window surrounding rs2378383 (located at the vertical blue line) is
shown. Data points in red show a significant under- (or over-) transmission of Native American ancestry with |z-score| greater than 1.96,
corresponding to an uncorrected p-value of 0.05.
doi:10.1371/journal.pgen.1000623.g003
Table 2. Replication testing for 11 top GWAS SNPs in an independent study of case–parent trios of Mexican ethnicity.
SNP
a Chr SNP type Gene
b
Minor
allele GWAS (N=492 trios) Replication study (N=177 trios)
MAF RR
c
Lower
CI
Upper
CI
Log-linear
p-value MAF RR
c
Lower
CI
Upper
CI
Log-linear
p-value
rs1867612 16 Intergenic (GOT2, CDH8) A 0.08 0.44 0.31 0.63 1.55610
26 0.11 1.11 0.68 1.84 0.67
rs2247572 8 Intronic KCNB2 T 0.15 1.88 1.45 2.44 1.94610
26 0.16 1.27 0.84 1.89 0.26
rs6063725 20 Intergenic (SALL4, ZFP64) C 0.34 1.56 1.30 1.89 3.52610
26 0.38 1.15 0.86 1.56 0.35
rs720810 20 Intergenic (SALL4, ZFP64) G 0.26 1.61 1.32 2.00 5.13610
26 0.32 1.16 0.85 1.61 0.34
rs2378383 9 Intergenic (CHCHD9, TLE4) G 0.22 0.61 0.49 0.76 7.10610
26 0.20 0.63 0.41 0.96 0.030
rs6951506 7 Intronic DOCK4 A 0.20 0.60 0.47 0.76 1.10610
25 0.24 0.88 0.62 1.26 0.50
rs3734083 5 Intronic GALNT10 T 0.18 1.68 1.33 2.13 1.21610
25 0.19 0.72 0.48 1.07 0.10
rs2378377 9 Intergenic (CHCHD9, TLE4) G 0.28 0.64 0.53 0.79 1.36610
25 0.28 0.71 0.50 1.02 0.061
rs4674039 2 Intergenic (FN1, MREG) C 0.42 0.67 0.56 0.81 1.51610
25 0.49 1.11 0.82 1.51 0.50
rs1830206 10 Intergenic (FZD8, ANKRD30A) G 0.26 1.55 1.27 1.89 2.17610
25 0.25 1.20 0.85 1.71 0.30
rs3814593 10 Intronic PITRM1 T 0.32 0.67 0.55 0.81 3.30610
25 0.35 0.82 0.58 1.15 0.24
aSNPs are ranked from smallest to largest GWAS p-value.
bGene names are listed for SNPs mapping within genes. For intergenic SNPs, the nearest genes (upstream, downstream) are listed.
cRelative risk for carrying one copy of the minor allele compared to carrying no copies.
doi:10.1371/journal.pgen.1000623.t002
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G allele is associated with a decreased risk for childhood asthma in
the GWAS and replication analyses (Table 2).
GWAS findings in the context of genome-wide
expression data
We examined gene expression patterns in 51 diverse human
tissues in the context of GWAS findings to determine whether
genes expressed in asthma relevant tissues ranked higher than
genes not expressed in such tissues and thus to assess the biological
plausibility of our overall GWAS findings. These results are
presented in Figure 4. In the 14,330 genes with GWAS SNPs in
the gene or nearby, median false discovery rate q-values (derived
from the GWAS p-values) were compared between genes
expressed versus genes not expressed in each of 51 human tissues.
Among the 51 tissues, the most significant deviation between the
median q-values was found between 3,618 genes expressed in the
lung versus 10,712 genes not expressed in the lung (Figure 4,
p=0.00025). This finding remains significant even after a
conservative Bonferroni correction for multiple testing. The q-
values for the 3,618 lung-expressed genes are presented in Table
S1. TLE4 did not contribute to the observation of significantly
lower GWAS q-values in lung-expressed genes, as TLE4 was
classified as not expressed. TLE4 displays a nearly ubiquitous
expression pattern with similar low intensity levels across many
tissues, so even though it is present in the lung, its expression level
in the lung did not exceed our 75
th percentile threshold to be
classified as expressed.
Other tissues in the respiratory and immune system also showed
deviations in the median GWAS q-values for expressed versus not
expressed genes, including thymus and lymph node at the p,0.01
level (uncorrected) and fetal lung, trachea, tonsil, smooth muscle,
and bronchial epithelium at the p,0.05 level (uncorrected). Thus,
SNPs in genes more highly expressed in tissues related to the
pathogenesis of asthma and allergies tend to give more significant
GWAS results than genes more highly expressed in other tissues.
These results give biological credibility to our overall GWAS
findings and are consistent with the multigenic etiology of asthma.
A two-dimensional cluster analysis was conducted to identify the
implicated tissues with correlated gene expression patterns. As
shown in Figure S2, lung tissue is grouped in a cluster with fetal
lung and placenta tissues, thus suggesting that gene expression
patterns in lung are most similar to gene expression patterns in
fetal lung and placenta and that their signals are correlated. There
are 2,385 genes classified as expressed in all three tissues – lung,
fetal lung, and placenta. The gene expression patterns of other
implicated tissues are also highly correlated, including the immune
tissues tonsil, lymph node, and thymus (Figure S2).
Figure 4. GWAS findings in the context of genome-wide expression. Genome-wide expression profiles were obtained from publicly available
Novartis Research Foundation data, and the gene expression patterns were examined in the context of GWAS results for 14,330 genes. P-values for
the Wilcoxon rank-sum test on the logarithmic scale indicate the significance in the difference of median GWAS q-values in genes expressed versus
genes not expressed in each of 51 human tissues. Significance thresholds of p,0.01 (solid line) and p,0.05 (dashed line) are shown.
doi:10.1371/journal.pgen.1000623.g004
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Genetic studies of asthma are few in Hispanic populations, and
to our knowledge, this work presents the first asthma GWAS in
Mexicans and the most extensive coverage of genetic variation for
an asthma GWAS in any Hispanic population. The GWAS
included 492 Mexican case-parent trios. Given the moderate
GWAS sample size, no SNP met genome-wide significance.
However, the ranking of GWAS SNPs highlighted a potentially
important candidate region for childhood asthma susceptibility,
chromosome 9q21.31. Several chromosome 9q21.31 SNPs with
small GWAS p-values were located in TLE4 and its upstream
region, and two of these SNPs (rs2378383 and rs2378377) were
tested for replication in an independent study of 177 case-parent
trios of Mexican ethnicity. Despite the small sample size for
replication, both SNPs gave p-values close to 0.05 and the same
direction and magnitude of association as the GWAS. Neither
rs2378383 nor rs2378377 have a known impact on TLE4
expression, but given their location upstream of TLE4,i ti s
possible that these SNPs reside in a TLE4 regulatory region.
Ancestry analysis in this chromosomal region provided
supportive evidence that rs2378383 (G) is associated with a
decreased risk of childhood asthma in Mexicans. Ancestry and
transmission-based association analyses provide complementary
but not completely independent lines of evidence. At each SNP,
the log-linear method only used parents who were heterozygous in
genotype, while ancestry analysis used all parents who are
heterozygous in ancestry, including parents who are homozygous
in genotype. We did not a priori expect that ancestry analysis results
would corroborate log-linear association results.
Our ancestry analysis uses the same principles that underlie
admixture mapping and relies on the key assumption of different
risk allele frequencies between the ancestral populations, primarily
Native American and European in this study. Under this
assumption, individuals with disease in the admixed population
would be expected to share an excess of ancestry from the
population with the highest risk allele frequency at the disease
locus [9]. In contrast, individuals with disease in the admixed
population would be expected to share a shortage of ancestry from
the population with the highest protective allele frequency at the
disease locus. At chromosome 9q21.31, there was less Native
American ancestry than expected, suggesting that the Native
American ancestral population had a higher frequency of the
protective rs2378383 allele (G).
Ancestry analysis implicated chromosome 9q21.31 as a
chromosomal region that may underlie ethnic differences in
childhood asthma. Complex diseases with differing disease
prevalence rates in the ancestral populations are most suitable
for ancestry analysis [15]. Prevalence rates of childhood asthma in
the true ancestral Native American, European, and African
populations are unknowable, but it is interesting to note that
Mexicans have the highest Native American ancestry and the
lowest asthma prevalence rate among Hispanic populations [16].
Differing frequencies of genetic risk factors in the ancestral
populations presumably contribute to the differing prevalence
rates of childhood asthma in modern populations. Our study
found an association between Native American ancestry and a
lower disease risk. Similarly, Native American ancestry was
associated with milder asthma in a previous study of subjects of
Mexican ethnicity from the GALA study [17]. These findings
collectively suggest that the Native American ancestral population
had higher frequencies of alleles that decrease prevalence and
severity of asthma in the modern Mexican population. A
comparison of asthma prevalence and severity among modern
Native Americans, Europeans, and Africans would further support
this interpretation, but such data are scarce [17].
The evidence for locus-specific ancestry around rs2378383 has
implications for replication. Because rs2378383 (G) occurs at
relatively low frequency in European, African and East Asian
populations, genetic association studies in these populations are
likely to suffer from lack of power at this locus. In contrast, the G
allele occurs at moderate frequency in the Native American
populations surveyed in HGDP [18]. Such disparate allele
frequencies facilitate ancestry analysis in the region and improve
the statistical power of transmission-based tests, as there are many
more heterozygous parents in the Mexican population than a
European, African or East Asian population. In fact, we obtained
association results for SNPs in the chromosome 9q21.31 region
from previous GWASs and found that SNPs in this region had
only nominal evidence for association with asthma in the GWASs
in white populations [5,7]. It is not surprising that substantial
evidence for replication was not found given the ethnicity
differences (whites for Moffatt et al. and Himes et al. [5,7] and
Puerto Ricans for Choudhry et al. [8]). Future replication and
fine-mapping of the region would be most effective if performed in
Native American populations, or admixed populations with high
Native American ancestral contributions.
The chromosome 9q21.31 SNPs associated with childhood
asthma in the GWAS map to TLE4 and its upstream region. The
TLE family of proteins in humans is homologous to the
Drosophila Groucho protein, which participates in cell fate
determination for neurogenesis and segmentation. The highly
conserved structure among the Drosophila Groucho and human
TLE gene products suggest similar functions as transcriptional
regulators in cell fate determination and differentiation [19]. Six
genes encode the TLE family of proteins in humans (TLE1, TLE2,
TLE3, TLE4, TLE5, TLE6), as deposited in the NCBI database.
The distinct expression patterns among the TLE genes suggest a
complex mechanism in humans involving non-redundant roles for
the TLE genes [20]. The TLE4 gene, in particular, shows
ubiquitous expression across many tissues [19,21], and TLE4
functions as a transcriptional co-repressor in several key
developmental pathways [22]. More specifically, TLE4 has been
implicated in early B-cell differentiation. TLE4 interacts with the
transcription factor Paired box 5 (PAX5; OMIM 167414), which
activates B-cell specific genes and represses alternative lineage fates
[23]. A spliced version of TLE4 acts as a negative regulator for the
PAX5/TLE4 function [23]. An alteration of B-cell differentiation
involving TLE4 could be relevant to immune development and
thus asthma.
TLE interacts with Runt-related transcription factor 3
(RUNX3; OMIM 600210) in a manner that may be directly
relevant to asthma. In mice, loss of RUNX3 function results in an
allergic asthma phenotype due to accelerated dendritic cell
maturation and resulting increased efficacy to stimulate T cells
[24]. Interaction with TLE is required for RUNX3 to inhibit
dendritic cell maturation [25]. A recent paper provides support for
the interaction of RUNX3 specifically with TLE4 [26]. Interest-
ingly, the chromosome 9q21.31 SNPs rs2378383 and rs2378377
near TLE4 are associated with asthma as well as degree of atopy in
our data, and their associations with asthma became more
pronounced when considering only the asthmatic children with
atopy and their parents. These findings suggest that the influence
of TLE4 on asthma may be related to its influence on immune
system development.
Childhood asthma is a complex disease, and there are likely
many susceptibility genes influencing immune system development
and asthma in the Mexican population. The examination of
GWAS for Asthma in Mexican Children
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biological plausibility of our GWAS findings and showed
consistency with the involvement of multiple genes. Genes
expressed in the lung show association signals that differ most
significantly from the association signals from genes not expressed
in the lung when compared to 50 other human tissues. The lung
represents a major pathogenic site for asthma, and this finding
implies that multiple genes expressed in the lung are collectively
associated with an increased risk of childhood asthma. Some of the
other implicated tissues may represent false positives, but several of
the highlighted tissues are biologically plausible for childhood
asthma, including trachea, bronchial epithelium, smooth muscle,
and immune tissues such as thymus, tonsil, and lymph node.
Other GWASs have implicated different susceptibility loci.
Several SNPs implicated in the first asthma GWAS by Moffatt et
al. in the ORMDL3 region [5] were associated with childhood
asthma in our GWAS [including rs9303277 (p=0.036),
rs11557467 (p=0.014), rs8067378 (p=0.020), rs2290400
(p=0.037), and rs7216389 (p=0.042)] but were not ranked
among our top 5,000 SNPs. More recent GWASs have implicated
loci other than ORMDL3. The PDE4D SNPs implicated by Himes
et al. [7] were not associated with childhood asthma in our GWAS
at p,0.05. Two nearby SNPs, not in LD with the implicated
SNPs, were associated [rs13158277 (p=0.030) and rs7717864
(p=0.015)] but were also not ranked among our top 5,000 SNPs.
Chromosome 5q23 SNPs implicated by Choudhry et al. [8] were
not associated with childhood asthma in our GWAS at p,0.05.
Initial GWAS findings regarded as replicated may not be ranked
among the front runners in a genome-wide scan in the replication
populations for statistical [27] as well as other biological reasons
(such as ethnic differences, phenotypic heterogeneity, genetic
heterogeneity, differing patterns of interacting environmental
exposures, or multigenic etiology). This trend in discordant
GWAS findings is quite common for various complex diseases
[28], and follow-up studies are crucial in separating true genetic
associations from false positives.
The major limitation of this study is the sample size for the
GWAS and replication study. The Mexican population is largely
under-studied given its size, and only moderate sample sizes are
currently available for the study of asthma genetics. In our study,
no SNPs met genome-wide significance, and no replication SNPs
met the significance threshold when using a conservative
Bonferroni correction for multiple testing. Despite this limitation,
top GWAS findings, replication in an independent population,
and ancestry analysis taken together implicate a novel region for
association with asthma in Mexican children.
This study has several strengths. The case-parent trio design
and the log-linear analysis protects against bias due to population
stratification [29], so our GWAS results are not confounded by
population stratification in this admixed population. Also, disease
misclassification is minimal. Although bronchial hyper-reactivity
was not tested, children with asthma were given reliable diagnoses
based on clinical grounds by pediatric allergists at a pediatric
allergy specialty clinic. The allergy clinic is a tertiary referral clinic,
so the children with asthma were previously seen by a generalist
and a pediatrician over time for recurrent asthma symptoms.
Physician diagnosis of asthma has been shown to have a high level
of validity in children after the first few years of life [30]. Further,
the asthmatic children were predominantly atopic to aeroallergens
based on skin prick testing limiting heterogeneity of the disease
phenotype.
The GWAS and replication association results and the supporting
ancestry analysis implicate chromosome 9q21.31 as a novel
susceptibility locus for childhood asthma in the Mexican population.
This region contains a biologically plausible novel susceptibility gene
for childhood asthma, TLE4, but further work is needed to decipher
whether TLE4 or a nearby gene explain the signals from the
chromosome 9q21.31 region. Further, childhood asthma is a
complex disease with a proposed multigenic etiology, but most single
studies will not have sufficient power to examine such complex
relationships. Identification of important interacting risk factors in
childhood asthma and other complex diseases will require very large
sample sizes. This work identifies chromosome 9q21.31 (including
TLE4) as a novel candidate susceptibility locus for childhood asthma,
suggests that this region may underlie ethnic differences in childhood
asthma, and emphasizes the presence of multiple genetic risk factors
in the complex mechanism leading to childhood asthma.
Materials and Methods
Ethics statement
The study protocol was approved by the Institutional Review
Boards of the Mexican National Institute of Public Health,
Hospital Infantil de Mexico Frederico Gomez, and the US
National Institute of Environmental Health Sciences (NIEHS).
Parents gave written informed consent for the children’s
participation, and children gave their assent.
Study subjects
Children with asthma (aged 5–17) and their biological parents
were recruited between June 1998 and November 2003 from a
pediatric allergy specialty clinic at a large public hospital in central
Mexico City, Hospital Infantil de Mexico Frederico Gomez. The
case-parent trio design protects against bias due to population
stratification in this admixed population [29,31]. Blood samples
were collected from enrolled children and their parents for DNA
extraction.
Children were diagnosed with asthma by a pediatric allergist at
the referral clinic based on clinical symptoms and response to
treatment [32]. Asthma severity was rated as mild (intermittent or
persistent), moderate, or severe by the pediatric allergist according
to symptoms in the Global Initiative on Asthma schema [33].
Questionnaires on the children’s asthma symptoms and risk
factors, including environmental tobacco smoking, were complet-
ed by parents, nearly always the mother.
The clinical evaluation also included skin prick testing to
measure atopy and pulmonary function testing, as previously
described [6]. A battery of 24 aeroallergens common in Mexico
City was used for skin prick testing. Histamine was used as a
positive control, and the test was considered valid if the histamine
reaction was 6 mm or greater [34]. Glycerin was used as a
negative control. Children were considered atopic if the diameter
of skin reaction to at least one allergen exceeded 4 mm.
Pulmonary function testing was performed at a later date using
the EasyOne spirometer (ndd Medical Technologies, Andover,
Massachusetts) according to American Thoracic Society guidelines
[35]. Children were asked to withhold asthma medications on the
morning of the test. The best test of three technically acceptable
tests was selected. Percent predicted forced expiratory volume in 1
second (FEV1) was calculated using spirometric prediction
equations from a childhood population in Mexico City [36].
Measurements of ambient ozone were obtained from the
Mexican government’s air monitoring station closest to each
child’s residence (within 5 km). The annual average of the daily
maximum 8 hour averages of the ozone level was collected for the
year prior to study entry and dichotomized at the median for
stratified analyses. Further details on the ozone measurement
protocol have been described elsewhere [6].
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control
Peripheral blood lymphocytes were isolated from whole blood,
and DNA was extracted using Gentra Puregene kits (Gentra
Systems, Minneapolis, Minnesota). A total of 498 complete case-
parent trios with previously confirmed parentage and sufficient
amounts of DNA were genotyped for 561,466 SNPs using the
Illumina HumanHap 550 K BeadChip, version 3 (Illumina, San
Diego, California) at the University of Washington, Department of
Genome Sciences. Genotypes were determined using the Illumina
BeadStudio Genotyping Module, following the recommended
conditions. Results for three unrelated study subjects fell below the
genotyping call rate threshold of 95% resulting in exclusion of
three trios. The remaining study subjects were genotyped with an
average call rate of 99.7%.
Quality control analyses were conducted using PLINK (http://
pngu.mgh.harvard.edu/,purcell/plink/) [37], unless otherwise
stated. In preliminary SNP-level quality control, SNPs were
excluded due to poor chromosomal mapping (N=173), missing-
ness.10% (N=988), MAF,0.001% (N=253), HWE p-value (in
parents only),1610
210 (N=557), Mendelian errors in more than
two families (N=4,945), and heterozygous genotype calls for
chromosome X SNPs in more than one male (N=380). All SNP
exclusions were made sequentially in the above order.
Subject-level quality control verified that no subjects had
unusual autosomal homozygosity or an inconsistent sex between
genotype and collected phenotype data. Subject-level quality
control next assessed subject relatedness to identify unknown intra-
and inter-family relationships. This identified two duplicated trios
and one trio with first-degree relative parents requiring exclusion.
Trio exclusions were not necessary for other identified relation-
ships, including parents in different trios being first-degree or
second-degree relatives and nuclear families with two children
with asthma being split into two case-parent trios. There were 492
complete case-parent trios (1,468 study subjects) in the final
analysis data set.
Final SNP-level quality control made exclusions due to one or
more discordant genotypes across 14 HapMap replicate samples
identified using the Genotyping Library and Utilities application
(http://code.google.com/p/glu-genetics/) (N=921) [38]. Final
SNP exclusions were also made due to more stringent missingness
and MAF thresholds, missingness.5% (N=3,137) and MAF,1%
(N=16,696). Of the 533,416 SNPs passing all quality control
criteria (95.0%), the 520,767 autosomal SNPs were analyzed for
purposes of this study.
Replication study subjects
Subjects of Mexican ethnicity from the GALA study were used
for replication testing. The GALA study protocol has been
described elsewhere [14]. Subjects of Mexican ethnicity with
physician-diagnosed asthma and presence of two or more asthma
symptoms in the past two years (wheezing, coughing, and
shortness of breath) were enrolled along with both biological
parents in San Francisco, California, US, and Mexico City,
Mexico. Total plasma IgE was measured for all subjects with
asthma.
The children with asthma in the GWAS (less than 18 years old)
were enrolled at a pediatric allergy clinic, so nearly all had allergic
asthma. To maximize comparability with the GWAS, the
replication study included only the 177 complete case-parent trios
comprising subjects of Mexican ethnicity having childhood-onset
(age of onset,18 years) asthma and atopy (total IgE.100 IU/mL)
and their parents.
Replication SNP selection and genotyping
SNPs were ranked by GWAS p-value. The top SNP and 10
other top ranking GWAS SNPs were tested for replication in the
GALA study. The highest ranking SNP along with 10 other top
ranking SNPs with no strong LD (r
2,0.9) with other higher-
ranked SNPs and MAF.10% were selected for replication.
Statistical power to detect associations in the replication study of
177 case-parent trios was calculated for each selected SNP using
QUANTO (http://hydra.usc.edu/gxe) [39]. The MAFs and RR
estimates observed from the GWAS with a log-additive model
were specified in the power calculation for each selected SNP.
Genotyping for replication SNPs was performed on the Applied
Biosystems (ABI, Foster City, California) PRISM 7500 Real-Time
PCR System using primers and probes from ABI’s Assay-by-
Demand. The assay was performed under universal conditions,
with each reaction containing 3.75 ng DNA, 0.125 mL 40X Assay
Mix and 2.5 mL TaqMan Universal PCR master mix brought to a
final volume of 5 mL with sterile water. Thermal cycling
conditions began at 95uC for 10 minutes and then proceeded
with 60 cycles of 92uC for 15 seconds and 60uC for 2 minutes.
After the PCR reaction, plates were scanned by the ABI PRISM
7500 PCR system to determine genotypes by allelic discrimina-
tion.
Statistical analysis of genotype data
The log-linear likelihood approach was used to examine
associations of individual SNPs with childhood asthma in the
GWAS and replication study [29,40]. The log-linear method is a
generalization of the classic family-based test for association
between genetic variants and disease, the transmission disequilib-
rium test [41], which compares the distribution of alleles
transmitted from parents to affected offspring with the distribution
of alleles not transmitted. An asymmetry of allele distributions
implies that the variant under study is associated with disease
within families. This inference requires the assumption of
Mendelian inheritance, such that the allele under study is not
related to the parents’ fertility or to the offspring’s survival [40].
The log-linear method and other transmission-based methods test
the same null hypothesis of no linkage or no association (i.e. no
LD) between the allele and disease [40]. Unlike other transmis-
sion-based methods, the log-linear method provides risk estimates
to assess the direction and magnitude of association.
Robustness to population stratification is a well-known property
of the case-parent trio design and transmission-based methods.
The log-linear method achieves robustness to population stratifi-
cation by stratifying on the six possible parental mating types,
which are defined by the number of copies of the allele carried by
each of the two parents [40]. The assumption of HWE is not
required for the log-linear method, but we tested for HWE in
parents as a check for genotyping error.
The log-linear method was implemented using the LEM
computer program [42] with a one degree-of-freedom log-additive
risk model specified. When missing genotypes occur, the log-linear
method uses the expectation-maximization algorithm to maximize
the likelihood, allowing incomplete trios to contribute information
and minimizing loss of statistical power [31]. P-values were
generated to assess statistical significance, and the RR of carrying
one copy of the risk allele was calculated to assess the direction and
magnitude of association. For the most significantly associated
GWAS SNPs, pair-wise LD was assessed in the parents using
PLINK (http://pngu.mgh.harvard.edu/,purcell/plink/) [37] or
HAPLOVIEW (http://www.broad.mit.edu/mpg/haploview/)
[43]. A combined p-value from meta-analysis of the GWAS and
replication association results was computed using MANTEL [44].
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tested for effect modification with environmental exposures
relating to air pollution and environmental tobacco smoking.
Data from the GWAS population were stratified by current
parental smoking (yes/no) and residential ambient ozone exposure
(stratified at the median of 67 ppb annual average of the daily
maximum 8 hour averages), and the log-linear method was used to
test for genetic associations in each stratum.
Additional analyses were conducted in the GWAS population
using the skin prick testing data. The genome-wide association
scan was repeated in the subset of trios with children classified as
atopic (one or more positive skin tests) in an effort to reduce
phenotypic heterogeneity and thus reduce genetic heterogeneity.
Then, an extension of the log-linear method for quantitative traits
[45] was used to test for associations of interesting SNPs with the
number of positive skin tests to a battery of 24 aeroallergens as a
measure of atopy. This analysis was performed only on the case-
parent trios with skin test data and complete genotype data.
Ancestry analysis
The program FRAPPE was used to estimate individual ancestry
proportions, assuming three ancestral populations: Native Amer-
ican, European, and African [46]. HapMap (phase 3) genotype
data from 109 individuals from the United States with northern
and western European descent and 108 individuals from Nigeria
were included to represent ancestral European and African
individuals, respectively. Genotype data from 35 Mayan and
Pima Indians were taken from the HGDP, which have been
genotyped using Illumina 650 K arrays [18], as the best available
representation of ancestral Native American individuals. Individ-
ual ancestry proportions were averaged across all study subjects to
determine the mean Native American, European, and African
ancestral contributions.
The program SABER was used to infer locus-specific ancestry
in each individual [47]. Our goal was to elucidate the pattern of
ancestry segregation near the replicated chromosome 9q SNP
(rs2378383). SNPs along chromosome 9q were analyzed to more
accurately infer ancestry, but since we were only interested in
examining the pattern of ancestry segregation at rs2378383 a priori,
a multiple testing correction was not applied. A trio-based ancestry
analysis test was implemented similar to that described in Clarke
and Whittemore [48], which parallels the transmission disequilib-
rium test [41]. Because the African ancestry in this population is
quite low (,5%), we tested Native American versus non-Native
American ancestry. At each SNP, parents were considered to have
no Native American ancestral alleles if their posterior Native
American ancestry was less than 0.1, one ancestral allele if
between 0.4 and 0.6, and two ancestral alleles if greater than 0.9.
Conservative thresholds were set to minimize misclassification.
Parents with intermediate ancestry estimates falling outside the
specified ranges were excluded, resulting in a 10% missing rate.
For parents who were heterozygous in ancestry, the null
hypothesis that the Native American allele is transmitted to the
children with probability equal to K was tested at each SNP [48].
Genome-wide expression data
The Genomics Institute of the Novartis Research Foundation
maintains a freely accessible database (http://symatlas.gnf.org) of
genome-wide expression profiles of the protein-encoding tran-
scriptome in many diverse human and mouse tissues and cell lines
[21]. As reported, tissue samples were predominantly obtained
from the normal physiological state [21]. The custom expression
array for humans targeted 44,775 transcripts corresponding to
known, predicted, and poorly characterized protein-encoding
genes [21]. We obtained the expression data for the 44,775
transcripts in 51 diverse human tissues and mapped these
transcripts to 15,047 unique genes after accounting for multiple
transcripts per gene and mapping to current nomenclature.
Gene expression patterns in the Novartis data were examined in
the context of GWAS results. Of the 15,047 genes with expression
data, 12,199 genes had at least one genotyped GWAS SNP
mapping within the gene, and an additional 2,131 genes had at
least one genotyped SNP mapping near the gene for a total of
14,330 genes. SNPs mapping within the 59- most extent to the 39-
most extent over all isoforms for a gene or within a larger region
expanded by 50 kb in both directions were considered. This
broader region was considered in order to capture potential
regulatory regions. For each gene, one false discovery rate q-value
was calculated using the log-linear p-values of SNPs mapping
within or near the gene based on a method for combining p-values
by Peng et al. [49]. Genes were then categorized as expressed or
not expressed in each of the 51 tissues examined. The expression
threshold was the 75
th percentile of normalized intensity values for
each tissue. The global median q-values across genes expressed
versus genes not expressed were calculated for each tissue, and a
two-tailed Wilcoxon rank-sum test was conducted to generate a
test of significance for this difference in median q-values.
Gene expression patterns are correlated across different tissues.
We performed a two-dimensional hierarchical clustering to
describe the correlation of expression patterns using Spearman’s
correlation coefficient across genes and across tissues. Genes and
tissues with similar gene expression patterns were grouped into
clusters using Ward’s distance as the linkage function to be
optimized. Partek Genomics Suite 6.08.1010 (Partek Inc., St.
Louis, Missouri) software was used to perform this analysis using
the continuous expression values in the 15,047 genes with
expression data.
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